Confo Therapeutics’ Post

We are delighted to share that our CEO, Cedric Ververken was awarded the “Private Company CEO of the Year” title at the 2023 European Lifestars Awards earlier this week in London. This award recognises Cedric’s leadership and the hard work of the entire Confo team resulting in multiple impactful deals in 2023. Confo was also voted 2nd place for the “Deal of the Year >€500M” category, recognizing our global licensing agreement with Eli Lilly and Company for CFTX-1554, our clinical-stage candidate for the treatment of peripheral pain. Congratulations to all winners! Additional details can be found at https://lnkd.in/eA_kB9-J   #lifestarawards #biotech #lifesciences